REGENESIS Appoints Scientist Vassilios Papadopoulos, Dean of the USC Mann School, to Board of Directors
By:
Regenesis via
GlobeNewswire
November 20, 2025 at 09:00 AM EST
SAN CLEMENTE, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- REGENESIS, a leader in advanced environmental and remediation technologies, today announced the appointment of noted scientist, inventor, and higher education leader Dr. Vassilios Papadopoulos, Dean of the University of Southern California (USC) Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, to its Board of Directors. Dr. Papadopoulos brings decades of experience in pharmaceutical sciences, biomedical research, and translational health innovation. His appointment reflects REGENESIS’ continued commitment to blending scientific leadership with cutting-edge development in environmental health solutions. “As a globally recognized researcher and health leader, Dr. Papadopoulos brings unique insight into how contaminants such as PFAS affect human health,” said Scott Wilson, CEO of REGENESIS. “His understanding of the biological pathways and health outcomes associated with environmental exposure will help guide our innovation strategy and new product development efforts.” At USC, Dr. Papadopoulos has led transformative initiatives in pharmaceutical research and development, building partnerships across academia, public health, and industry. His expertise in molecular mechanisms related to environmental factors aligns closely with REGENESIS’ mission to develop sustainable technologies that address PFAS contamination and other persistent pollutants in soil and groundwater. “I am honored to join the REGENESIS Board at a time when environmental health challenges are driving new scientific and commercial frontiers,” said Dr. Papadopoulos. “Together, we can advance innovative, science-based solutions that protect water quality and improve community health outcomes.” REGENESIS continues to expand its portfolio of in situ technologies for groundwater and soil remediation. The addition of Dr. Papadopoulos strengthens the company’s scientific advisory capacity and supports its long-term goal of integrating human health perspectives into environmental technology design. Media Contact:
More NewsView MoreVia MarketBeat
Why Palantir Slide May Be a Setup for a Long-Term Opportunity ↗
Today 10:36 EST
Via MarketBeat
Attention Income Investors: This REIT Is on Sale ↗
Today 9:01 EST
Via MarketBeat
Tickers
RKLB
MarketBeat Week in Review – 11/17 - 11/21 ↗
Today 7:00 EST
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
